Beyond Anaemia Management: Evolving Role of Erythropoietin Therapy in Neurological Disorders, Multiple Myeloma and Tumour Hypoxia Models

Publisher： Karger

E-ISSN： 1423-0232|69|2|22-30

ISSN： 0030-2414

Source： Oncology, Vol.69, Iss.2, 2005-10, pp. : 22-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Erythropoietin in Patients with Multiple Myeloma

By  

Oncology Research and Treatment, Vol. 26, Iss. 1, 2003-03 ,pp. : 80-84

Karger

Access to resources Recommend Favorite

Antiangiogenic Therapy in Multiple Myeloma

By  

Acta Haematologica, Vol. 106, Iss. 4, 2002-01 ,pp. : 208-213

Karger

Access to resources Recommend Favorite

The Emerging Role of Arsenic Trioxide as an Immunomodulatory Agent in the Management of Multiple Myeloma

By  

Acta Haematologica, Vol. 116, Iss. 1, 2006-07 ,pp. : 1-7

Karger

Access to resources Recommend Favorite

Evolving Treatments in Multiple Myeloma Patients with Renal Failure

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 4, 2014-12 ,pp. : 276-279

Bentham Science Publishers

Access to resources Recommend Favorite

Anti‐tumour activity of interferon‐alpha in multiple myeloma: role of interleukin 6 and tumor cell differentiation

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 121, Iss. 2, 2003-04 ,pp. : 251-258

John Wiley & Sons Inc

Access to resources Recommend Favorite